In addition, treatment with the macrophage stimulating cytokine granulocyte-macrophage colony-stimulating factor (GM-CSF) enhances the efficacy of anti-CD20 and anti-GD2 antibodies for the elimination of neuroblastoma [7]. This evidence concerns the gene CSF2 and neuroblastoma.